These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2443320)

  • 1. [Restoration of ovulation in women after long-term use of long-acting monthly oral contraceptives: 16-methylene chlormadinone compound].
    Hu ZZ
    Zhonghua Fu Chan Ke Za Zhi; 1987 May; 22(3):167-9, 191. PubMed ID: 2443320
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum prolactin and gonadotropins during the normal menstrual cycle and during oral contraceptives].
    Vekemans M; L'Hermite M; Robyn C
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):354-6. PubMed ID: 4143445
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiovulatory action of chlormadinone acetate].
    Pelissier C; Blacker C; Feinstein MC; Cournot A; Denis C
    Contracept Fertil Sex; 1994 Jan; 22(1):37-40. PubMed ID: 7511024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antigonadrotropic activity of chlormadinone acetate in reproductive women. Gynecol Obstet Fertil 2005;33:29-34].
    Jamin C
    Gynecol Obstet Fertil; 2005; 33(7-8):554-5. PubMed ID: 16005664
    [No Abstract]   [Full Text] [Related]  

  • 5. Levels of serum follicle-stimulating hormone, luteinizing hormone, and plasma progestin during microdose chlormadinone treatment.
    Taymor ML; Levesque LA
    Fertil Steril; 1971 Jan; 22(1):1-8. PubMed ID: 4099041
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antigonadrotropic activity of chlormadinone acetate in reproductive women. Gynecol Obstet Fertil 2005;33:29-34].
    Dewailly D
    Gynecol Obstet Fertil; 2005; 33(7-8):555-6. PubMed ID: 16005673
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of ovulation by gestagens.
    Johansson E; Larsson-Cohn U; Nygren KG; Jeppsson S; Victor A; Weiner E
    Ups J Med Sci Suppl; 1978; 22():16-22. PubMed ID: 274856
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women.
    Swerdloff RS; Odell WD
    J Clin Endocrinol Metab; 1969 Feb; 29(2):157-63. PubMed ID: 4179302
    [No Abstract]   [Full Text] [Related]  

  • 9. Concentration of luteinizing and follicle-stimulating hormones in peripheral and ovarian venous plasma.
    Llerena LA; Guevara A; Lobotsky J; Lloyd CW; Weisz J; Pupkin M; Zanartu J; Puga J
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1083-9. PubMed ID: 4184697
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma levels of FSH and LH during the menstrual cycle, the menopause and in the course of gestagen treatment].
    Czygan PJ
    Acta Endocrinol Suppl (Copenh); 1971; 152():2. PubMed ID: 4101326
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term contraceptive effect of injectable progestogens: inhibition and reestabilishment of fertility.
    Zañartu J
    Int J Fertil; 1968; 13(4):415-26. PubMed ID: 4178183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antigonadrotropic activity of chlormadinone acetate in reproductive women].
    Chassard D; Schatz B
    Gynecol Obstet Fertil; 2005; 33(1-2):29-34. PubMed ID: 15752663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contraceptive effect of low-dosage ovulation inhibitors containing various progestagen agents].
    Mall-Haefeli M; Werner-Zodrow I; Huber PR
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):177-9. PubMed ID: 6427058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two-stage therapy as a method of hormonal contraception in comparison with compound preparations].
    Rothe K
    Z Gesamte Hyg; 1970 Apr; 16(4):289-90. PubMed ID: 4108397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with low dosage progesterone therapy].
    Minucci D; Ambrosini A; Polito PM; De Laurentiis G
    Riv Ital Ginecol; 1969 Mar; 53(3):202-12. PubMed ID: 4103432
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.
    Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
    Contraception; 2009 Feb; 79(2):111-6. PubMed ID: 19135567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effect and mechanism of action in the continuous oral therapy using microdosis of chlormadinone acetate for the control of human fertility].
    Zañartu J; Rodriguez-Moore G; Pupkin M; Rosenberg D; Davansens A; Guerrero R; Rodriguez-Bravo R; Garcia-Huidobro M; Puga JA
    Rev Med Chil; 1968 Nov; 96(11):739-46. PubMed ID: 4180031
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of oral contraceptives on bone density in climacteric females].
    Enzelsberger H; Metka M; Heytmanek G; Huber J
    Zentralbl Gynakol; 1989; 111(14):967-73. PubMed ID: 2508368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing hormone levels in plasma and urine in women during normal menstrual cycles and in women taking combined contraceptives or chlormadinone acetate.
    Orr AH; Elstein M
    J Endocrinol; 1969 Apr; 43(4):617-24. PubMed ID: 4181215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.